U.S. Autoinjectors MarketU.S. Autoinjectors Market Navigating Dynamics Comprehensive Analysis and Forecasts 2024-2032
U.S. Autoinjectors Market by Type (Disposable, Reusable), by Application (Autoimmune Disorders, Diabetes, Emergency Care, Others), by Route of Administration (Intramuscular, Subcutaneous), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), by Forecast 2024-2032
Base Year: 2023
120 Pages
U.S. Autoinjectors Market Navigating Dynamics Comprehensive Analysis and Forecasts 2024-2032
Key Insights
The U.S. Autoinjectors Market size was valued at USD 55 USD Billion in 2023 and is projected to reach USD 114.19 USD Billion by 2032, exhibiting a CAGR of 11.0 % during the forecast period. Autoinjectors are medical tools that serve as self-injector devices for self-administration of a precise amount of dosage of the medication. There are many variants encompass the spring-powered, the compressed air variants, and the automatic ones. Features are usually easy to use with one-touch operation, while some offer needle shield protection and they are portable as they are compact for transport. They help treat anaphylaxis, autoimmune disease, and emergencies from opioid overdose. To mention, they can be used by medics and nurses that have undergone minimal training and can give the necessary dosage rapidly. In the USA the market of autoinjectors is seeing a sustained rise in terms of increase in the number of chronic diseases where patients have to go through daily injections, improvements in the drug delivery technology, and a growing demand for self-administration options especially in the at-home healthcare services.
U.S. Autoinjectors Trends
Convenient and Easy Drug Delivery:
- Autoinjectors offer a convenient and user-friendly method for self-administration of medications, making them ideal for patients who need frequent or immediate injections.
Rising Prevalence of Chronic Diseases:
- The increasing incidence of chronic diseases such as diabetes, autoimmune disorders, and allergies is driving the demand for autoinjectors for medication administration.
Driving Forces: What's Propelling the U.S. Autoinjectors Market
- Technological Advancements: Innovations in autoinjector designs and features, such as improved needle designs and self-administration capabilities, are enhancing patient convenience and acceptance.
- Increased Patient Empowerment: Autoinjectors empower patients to self-manage their medications, reducing the burden on healthcare providers and improving overall patient care.
- Government Support: Government initiatives and reimbursement policies that support the use of autoinjectors are contributing to increased market growth.
Challenges and Restraints in the U.S. Autoinjectors Market
- Cost Concerns: Autoinjectors can be more expensive than traditional syringes, potentially limiting their accessibility for some patients.
- Patient Fear of Injections: Some patients may experience anxiety or reluctance to self-inject, which can hinder the adoption of autoinjectors.
- Regulatory Compliance: Strict regulatory requirements for autoinjector manufacture and distribution can be a barrier to market entry for new players.
Emerging Trends in U.S. Autoinjectors
- Connected Autoinjectors: Integration with mobile devices and digital health platforms allows for remote monitoring, medication adherence tracking, and personalized feedback.
- Biologics Delivery: Autoinjectors are being adapted to deliver complex biologics, such as monoclonal antibodies and peptides, which requires advanced delivery systems.
- Combination Devices: Autoinjectors are being combined with other technologies, such as smart pens and insulin pumps, to create comprehensive drug delivery solutions.
Growth Catalysts in U.S. Autoinjectors Industry
- Research and Development: Continuous advancements in autoinjector technology, including needle design, drug formulation, and delivery mechanisms, are driving market growth.
- Expansion of Therapeutic Applications: Autoinjectors are finding use in a wider range of therapeutic areas, from emergency care to hormonal therapies, broadening their potential customer base.
- Partnerships and Mergers: Strategic alliances between manufacturers and pharmaceutical companies are accelerating the development and commercialization of autoinjector products.
Market Segmentation: U.S. Autoinjectors Analysis
Type:
- Disposable
- Reusable
Application:
- Autoimmune Disorders
- Diabetes
- Emergency Care
- Others
Route of Administration:
- Intramuscular
- Subcutaneous
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Leading Players in the U.S. Autoinjectors Market
- Viatris Inc. (U.S.)
- Teva Pharmaceutical Industries Ltd. (Netherlands)
- Ypsomed AG (Switzerland)
- Recipharm AB (Sweden)
- BD (U.S.)
- Halozyme, Inc. (U.S.)
- AstraZeneca (U.K.)
- Bristol-Myers Squibb (U.S.)
- Phillips-Medisize (U.S.)
- SHL Medical AG (Switzerland)
- Xeris Pharmaceuticals, Inc. (U.S.)
Significant Developments in U.S. Autoinjectors Sector
- 2021: Mylan launches EpiPen Jr. Auto-Injector, a smaller version of its popular EpiPen for children.
- 2022: Eli Lilly acquires Akcea Therapeutics, gaining access to its autoinjector-based RNAi therapies for treating genetic diseases.
- 2023: AmerisourceBergen and CNS Healthcare collaborate to improve access to autoinjectors for patients with chronic conditions.
Comprehensive Coverage U.S. Autoinjectors Market Report
The report covers:
- Market Size and Forecast
- Market Trends and Drivers
- Challenges and Restraints
- Emerging Trends
- Growth Catalysts
- Market Segmentation
- Competitive Landscape
- Company Profiles
- Industry Developments
- Regional Analysis
- Import and Export Analysis
- Pricing Analysis
- DROCT Analysis
- Patent/Trademark Analysis
Regional Insight
The U.S. autoinjectors market is geographically segmented into the following regions:
- Northeast
- South
- Midwest
- West
DROCs
Drivers:
- Technological Advancements
- Increased Patient Empowerment
- Government Support
Restraints:
- Cost Concerns
- Patient Fear of Injections
- Regulatory Compliance
Opportunities:
- Connected Autoinjectors
- Biologics Delivery
- Combination Devices
Challenges:
- Intense Competition
- Lack of Reimbursement for Some Autoinjectors
- Patient Adoption Barriers
Pricing Analysis
Autoinjector prices in the U.S. vary depending on factors such as type, application, and manufacturer. Disposable autoinjectors typically range from USD 50 to USD 200, while reusable autoinjectors can cost up to USD 1,000.
Import And Export Analysis
The U.S. imports a significant amount of autoinjectors from countries such as China, Mexico, and Ireland. Export markets for U.S.-made autoinjectors include Europe and Asia-Pacific.
Segmentation
The U.S. autoinjectors market is segmented by type, application, route of administration, distribution channel, and region. This segmentation helps in identifying the growth potential of each segment and provides insights for market players to target specific areas.
U.S. Autoinjectors Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 11.0 % from 2018-2032 |
| Segmentation |
|
Frequently Asked Questions
Table Of Content
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Demand for Reusable Devices to Boost Market Growth
- 3.3. Market Restrains
- 3.3.1. Availability of Alternative Self-Injection Devices May Limit Product Adoption
- 3.4. Market Trends
- 3.4.1. Surging Demand for Self-Injection Devices
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. U.S. Autoinjectors Market Analysis, Insights and Forecast, 2018-2030
- 5.1. Market Analysis, Insights and Forecast - by Type
- 5.1.1. Disposable
- 5.1.2. Reusable
- 5.2. Market Analysis, Insights and Forecast - by Application
- 5.2.1. Autoimmune Disorders
- 5.2.2. Diabetes
- 5.2.3. Emergency Care
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by Route of Administration
- 5.3.1. Intramuscular
- 5.3.2. Subcutaneous
- 5.4. Market Analysis, Insights and Forecast - by Distribution Channel
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - by Region
- 5.5.1.
- 5.1. Market Analysis, Insights and Forecast - by Type
- 6. Northeast U.S. Autoinjectors Market Analysis, Insights and Forecast, 2018-2030
- 6.1. Market Analysis, Insights and Forecast - By Type
- 6.1.1. Disposable and Reusable
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1 Autoimmune Disorders
- 6.2.2 Diabetes
- 6.2.3 Emergency Care
- 6.2.4 and Others
- 6.3. Market Analysis, Insights and Forecast - By Route of Administration
- 6.3.1. Intramuscular and Subcutaneous
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1 Hospital Pharmacies
- 6.4.2 Retail Pharmacies
- 6.4.3 and Others
- 7. Southeast U.S. Autoinjectors Market Analysis, Insights and Forecast, 2018-2030
- 7.1. Market Analysis, Insights and Forecast - By Type
- 7.1.1. Disposable and Reusable
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1 Autoimmune Disorders
- 7.2.2 Diabetes
- 7.2.3 Emergency Care
- 7.2.4 and Others
- 7.3. Market Analysis, Insights and Forecast - By Route of Administration
- 7.3.1. Intramuscular and Subcutaneous
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1 Hospital Pharmacies
- 7.4.2 Retail Pharmacies
- 7.4.3 and Others
- 8. Midwest U.S. Autoinjectors Market Analysis, Insights and Forecast, 2018-2030
- 8.1. Market Analysis, Insights and Forecast - By Type
- 8.1.1. Disposable and Reusable
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1 Autoimmune Disorders
- 8.2.2 Diabetes
- 8.2.3 Emergency Care
- 8.2.4 and Others
- 8.3. Market Analysis, Insights and Forecast - By Route of Administration
- 8.3.1. Intramuscular and Subcutaneous
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1 Hospital Pharmacies
- 8.4.2 Retail Pharmacies
- 8.4.3 and Others
- 9. Southwest U.S. Autoinjectors Market Analysis, Insights and Forecast, 2018-2030
- 9.1. Market Analysis, Insights and Forecast - By Type
- 9.1.1. Disposable and Reusable
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1 Autoimmune Disorders
- 9.2.2 Diabetes
- 9.2.3 Emergency Care
- 9.2.4 and Others
- 9.3. Market Analysis, Insights and Forecast - By Route of Administration
- 9.3.1. Intramuscular and Subcutaneous
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1 Hospital Pharmacies
- 9.4.2 Retail Pharmacies
- 9.4.3 and Others
- 10. West U.S. Autoinjectors Market Analysis, Insights and Forecast, 2018-2030
- 10.1. Market Analysis, Insights and Forecast - By Type
- 10.1.1. Disposable and Reusable
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1 Autoimmune Disorders
- 10.2.2 Diabetes
- 10.2.3 Emergency Care
- 10.2.4 and Others
- 10.3. Market Analysis, Insights and Forecast - By Route of Administration
- 10.3.1. Intramuscular and Subcutaneous
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1 Hospital Pharmacies
- 10.4.2 Retail Pharmacies
- 10.4.3 and Others
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2023
- 11.2. Company Profiles
- 11.2.1 Viatris Inc. (U.S.)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Teva Pharmaceutical Industries Ltd. (Netherlands)
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Ypsomed AG (Switzerland)
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Recipharm AB (Sweden)
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 BD (U.S.)
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Halozyme Inc. (U.S.)
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 AstraZeneca (U.K.)
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Bristol-Myers Squibb (U.S.)
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Phillips-Medisize (U.S.)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 SHL Medical AG (Switzerland)
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Xeris Pharmaceuticals Inc. (U.S.)
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.1 Viatris Inc. (U.S.)
List of Figures
- Figure 1: U.S. Autoinjectors Market Revenue Breakdown (USD Billion, %) by Product 2023 & 2031
- Figure 2: U.S. Autoinjectors Market Value Share (%), by Type 2023 & 2031
- Figure 3: U.S. Autoinjectors Market Value Share (%), by Application 2023 & 2031
- Figure 4: U.S. Autoinjectors Market Value Share (%), by Route of Administration 2023 & 2031
- Figure 5: U.S. Autoinjectors Market Value Share (%), by Distribution Channel 2023 & 2031
- Figure 6: U.S. Autoinjectors Market Share (%) by Company 2023
List of Tables
- Table 1: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 2: U.S. Autoinjectors Market Volume K Units Forecast, by Type 2018 & 2031
- Table 3: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 4: U.S. Autoinjectors Market Volume K Units Forecast, by Application 2018 & 2031
- Table 5: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 6: U.S. Autoinjectors Market Volume K Units Forecast, by Route of Administration 2018 & 2031
- Table 7: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 8: U.S. Autoinjectors Market Volume K Units Forecast, by Distribution Channel 2018 & 2031
- Table 9: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Region 2018 & 2031
- Table 10: U.S. Autoinjectors Market Volume K Units Forecast, by Region 2018 & 2031
- Table 11: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 12: U.S. Autoinjectors Market Volume K Units Forecast, by Type 2018 & 2031
- Table 13: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 14: U.S. Autoinjectors Market Volume K Units Forecast, by Application 2018 & 2031
- Table 15: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 16: U.S. Autoinjectors Market Volume K Units Forecast, by Route of Administration 2018 & 2031
- Table 17: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 18: U.S. Autoinjectors Market Volume K Units Forecast, by Distribution Channel 2018 & 2031
- Table 19: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Region 2018 & 2031
- Table 20: U.S. Autoinjectors Market Volume K Units Forecast, by Region 2018 & 2031
- Table 21: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 22: U.S. Autoinjectors Market Volume K Units Forecast, by Type 2018 & 2031
- Table 23: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 24: U.S. Autoinjectors Market Volume K Units Forecast, by Application 2018 & 2031
- Table 25: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 26: U.S. Autoinjectors Market Volume K Units Forecast, by Route of Administration 2018 & 2031
- Table 27: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 28: U.S. Autoinjectors Market Volume K Units Forecast, by Distribution Channel 2018 & 2031
- Table 29: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Country 2018 & 2031
- Table 30: U.S. Autoinjectors Market Volume K Units Forecast, by Country 2018 & 2031
- Table 31: Northeast U.S. Autoinjectors Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 32: Northeast U.S. Autoinjectors Market Volume (K Units) Forecast, by Application 2018 & 2031
- Table 33: Southeast U.S. Autoinjectors Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 34: Southeast U.S. Autoinjectors Market Volume (K Units) Forecast, by Application 2018 & 2031
- Table 35: Midwest U.S. Autoinjectors Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 36: Midwest U.S. Autoinjectors Market Volume (K Units) Forecast, by Application 2018 & 2031
- Table 37: Southwest U.S. Autoinjectors Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 38: Southwest U.S. Autoinjectors Market Volume (K Units) Forecast, by Application 2018 & 2031
- Table 39: West U.S. Autoinjectors Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
- Table 40: West U.S. Autoinjectors Market Volume (K Units) Forecast, by Application 2018 & 2031
- Table 41: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Type 2018 & 2031
- Table 42: U.S. Autoinjectors Market Volume K Units Forecast, by Type 2018 & 2031
- Table 43: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Application 2018 & 2031
- Table 44: U.S. Autoinjectors Market Volume K Units Forecast, by Application 2018 & 2031
- Table 45: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Route of Administration 2018 & 2031
- Table 46: U.S. Autoinjectors Market Volume K Units Forecast, by Route of Administration 2018 & 2031
- Table 47: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
- Table 48: U.S. Autoinjectors Market Volume K Units Forecast, by Distribution Channel 2018 & 2031
- Table 49: U.S. Autoinjectors Market Revenue USD Billion Forecast, by Country 2018 & 2031
- Table 50: U.S. Autoinjectors Market Volume K Units Forecast, by Country 2018 & 2031
| Aspects | Details |
|---|---|
| Study Period | 2018-2032 |
| Base Year | 2023 |
| Estimated Year | 2024 |
| Forecast Period | 2024-2032 |
| Historical Period | 2018-2023 |
| Growth Rate | CAGR of 11.0 % from 2018-2032 |
| Segmentation |
|
STEP 1 - Identification of Relevant Samples Size from Population Database
STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.
Note* : In applicable scenarios
STEP 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
STEP 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
About Market Research Forecast
MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.
Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.
